Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.91 USD | +2.81% | +5.04% | +45.90% |
05-10 | Crinetics Pharmaceuticals Insider Sold Shares Worth $5,307,931, According to a Recent SEC Filing | MT |
05-09 | Crinetics Pharmaceuticals Q1 Net Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.90% | 4.09B | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+48.71% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- CRNX Stock
- News Crinetics Pharmaceuticals, Inc.
- Piper Sandler Initiates Coverage on Crinetics Pharmaceuticals With Overweight Rating, $56 Price Target